Expertise in
11
conditions

Eyal Shteyer

Shmuel Bait St 12, 
Jerusalem, JM, IL 
Expertise in
11
conditions
Shmuel Bait St 12, 
Jerusalem, JM, IL 

Overview

Eyal Shteyer practices practicing medicine in Jerusalem, Israel.

Mr. Shteyer is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Sclerosing Cholangitis, Progressive Familial Intrahepatic Cholestasis Type 1, Cholangitis, Liver Transplant, and Endoscopy.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Shmuel Bait St 12, Jerusalem, JM, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: Odevixibat
Study Phase: Phase 3
A Multicenter, Open-Label, Single- and Multiple-Dose, Dose-Finding Study, With an Optional Open-Label Extension to Assess the Safety, Tolerability, and Pharmacokinetics of Obeticholic Acid in Pediatric Subjects With Biliary Atresia
A Multicenter, Open-Label, Single- and Multiple-Dose, Dose-Finding Study, With an Optional Open-Label Extension to Assess the Safety, Tolerability, and Pharmacokinetics of Obeticholic Acid in Pediatric Subjects With Biliary Atresia
Enrollment Status: Terminated
Publish Date: March 28, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

72 Total Publications

Correction: Human DNA levels in feces reflect gut inflammation and associate with presence of gut species in IBD patients across the age spectrum.
Correction: Human DNA levels in feces reflect gut inflammation and associate with presence of gut species in IBD patients across the age spectrum.
Journal: Microbiome
Published: May 08, 2026

Frequently Asked Questions about Eyal Shteyer

Is Eyal Shteyer a top-rated expert for Sclerosing Cholangitis?

MediFind is an objective health platform that identifies experts based on real-world data. Eyal Shteyer is classified as an Distinguished expert for Sclerosing Cholangitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Eyal Shteyer participate in research or clinical trials?

Yes. Eyal Shteyer has published 72 articles and abstracts on conditions like Sclerosing Cholangitis. You can view a list of Eyal Shteyer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Shteyer's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile